Clinical implementation of pharmacogenomics (PGx) leads to personalized medicine, which
improves the efficacy, safety, and cost-effectiveness of treatments. Although PGx-based …

Purpose Existing pharmacogenomic informatics models, key implementation steps, and
emerging resources to facilitate the development of pharmacogenomic clinical decision …

Numerous pharmacogenetic clinical guidelines and recommendations have been
published, but barriers have hindered the clinical implementation of pharmacogenetics. The …

CYP2C19 genotype‐guided antiplatelet therapy following percutaneous coronary
intervention is increasingly implemented in clinical practice. However, challenges such as …

Advances in technologies for assessing genomic variation and an increasing understanding
of the effects of genomic variants on health and disease are driving the transition of …

Purpose The development and implementation of a multidisciplinary pharmacogenomics
clinic within the framework of an established community-based medical genetics program …

Background Pharmacogenetics practice has been successfully implemented in many
developed countries to enhance personalized medicine and improve clinical and economic …

The number of clinically relevant gene‐based guidelines and recommendations pertaining
to drug prescribing continues to grow. Incorporating gene–drug interaction information into …

Cardiovascular and renal diseases are associated with many risk factors, of which
hypertension is one of the most prevalent. Worldwide, blood pressure control is only …

Purpose The current state of pharmacogenomics education for pharmacy students and
practitioners is discussed, and resources and strategies to address persistent challenges in …